Traditional 503A compounding pharmacies and 503B outsourcing manufacturers both serve as important partners for veterinary practices, providing patient-specific prescriptions and manufacturing bulk drugs for in-practice
Quick Facts: The veterinary compounding market is expected to increase from US$ 1.1 Bn in 2020 to over US$ 2.7 Bn by 2031, expanding at
The following blog is written by Epicur Pharma’s Advisory Council member Jan Woods, a veterinary hospital consultant, and national speaker with expertise in DEA compliance,
Many veterinary medicines are sensitive to light. Proper packaging of veterinary pharmaceuticals makes a big difference. Improper packaging which exposes the medicine to light can
In veterinary medicine, trust is crucial to patient care. This is true for hospital’s relationships with its patients and clients, but trust is also necessary
The Main Takeaways: Expiration dates, which are used by 503B manufacturers offer benefits to veterinary patient care that beyond-use dates do not. Using medications that
Become a subscriber! You will receive all the latest blogs, product info, and veterinary care best practices.
Browse by Category
All information provided on this site is for educational purposes only. Every effort has been made to provide accurate and up-to-date information. It is not intended to be used as medical advice for the diagnosis of health problems nor does it include all possible uses, actions, safety measures, side effects, or interactions. Please consult a healthcare provider or veterinarian for the diagnosis and treatment of any health conditions. Epicur Pharma® manufactured veterinary orders are for non food chain animals only. Epicur Pharma® is registered with the FDA as an outsourcing facility.
© 2023 Epicur Pharma®
Epicur Pharma®
8000 Commerce Parkway, Ste. 600
Mount Laurel, NJ 08054
AAHA Strategic Alliance Program
Bronze Member
VHMA Business Alliance
Gold Partner
